ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources

Clinical Nuclear Medicine

Volumn 36, Issue 8, 2011, Pages

  Henkin, Robert E ^a   Del Rowe, John D ^b   Grigsby, Perry W ^c   Hartford, Alan C ^d   Jadvar, Hossein ^e   MacKlis, Roger M ^f   Parker, J Anthony ^g   Wong, Jeffrey Y C ^h   Rosenthal, Seth A ⁱ  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁱ Radiological Associates of Sacramento Medical Group Inc   (United States)

Author keywords

iodine 131; phosphorous 32; radionuclide therapy; radiopharmaceutical; samarium 153; strontium 89; unsealed sources; yttrium 90

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTIBODY; ANTIHISTAMINIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHROMIUM PHOSPHATE P 32; CORTICOSTEROID; CYTOTOXIC AGENT; IBRITUMOMAB TIUXETAN; IODINE 123; IODINE 131; LEXIDRONAM SAMARIUM SM 153; LUGOL; MICROSPHERE; PHOSPHATE P 32; POTASSIUM IODIDE; RADIOPHARMACEUTICAL AGENT; RECOMBINANT THYROTROPIN; RITUXIMAB; SAMARIUM 153 ANTIBODY; SODIUM IODIDE I 131; STRONTIUM 89; STRONTIUM 89 ANTIBODY; STRONTIUM CHLORIDE SR 89; THIONAMIDE; THYROID HORMONE; THYROTROPIN; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; UNINDEXED DRUG; YTTRIUM 90 ANTIBODY;

ABLATION THERAPY; ARTICLE; ASCITES; B CELL LYMPHOMA; BIRTH DEFECT; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; BRACHYTHERAPY; BRAIN CYST; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; COLLOID; CYTOPENIA; DIARRHEA; DISTANT METASTASIS; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED CANCER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; FEMALE INFERTILITY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFECTION CONTROL; IODONE AVID THYROID CANCER; LINEAR ENERGY TRANSFER; LIQUID; LIVER CANCER; MYELOPROLIFERATIVE DISORDER; NAUSEA; NONHODGKIN LYMPHOMA; ODYNOPHAGIA; OVARY CANCER; PATIENT EDUCATION; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; QUALITY CONTROL; RADIATION ABSORPTION; RADIATION PROTECTION; RADIATION SAFETY; RADIOIMMUNOTHERAPY; RADIOISOTOPE THERAPY; SIALOADENITIS; SINGLE DRUG DOSE; THROMBOCYTOSIS; THYROID CANCER; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROIDITIS; TOTAL QUALITY MANAGEMENT; TOXIC GOITER; VOMITING; XEROSTOMIA;

ABLATION TECHNIQUES; ASCITES; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOCUMENTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; INFECTION CONTROL; LYMPHOMA, NON-HODGKIN; OVARIAN NEOPLASMS; PAIN; PATIENT EDUCATION AS TOPIC; PLEURAL EFFUSION; POLYCYTHEMIA VERA; POSTOPERATIVE PERIOD; QUALITY CONTROL; RADIATION ONCOLOGY; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS; RADIOTHERAPY; SAFETY; SOCIETIES, MEDICAL; THROMBOCYTOSIS; THYROID NEOPLASMS;

EID: 79960239012     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318224b814     Document Type: Article

References (14)

1. ACR technical standard for diagnostic procedures using radiopharmaceuti-cals. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 1203-1209.
2. Federal Drug Administration. Supplement Approval Letter (Zevalin). Avail¬able at: http://www.accessdata.fda.gov/drugsatfda-docs/appletter/2009/ 125019s0156ltr.pdf. Accessed October 29, 2009.
3. Federal Drug Administration. Highlights of Prescribing Information (Zeva-lin). Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2009/125019s0156.pdf. Accessed October 29, 2009.
4. Practice guideline for radioembolization with microsphere brachytherapy device (RMBD) for treatment of liver malignancies. Practice Guideline and Technical Standards. Reston, VA: American College of Radiology; 2008: 1003-1016.
5. ACR practice guideline for radiation oncology. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 923-929.
6. ACR practice guideline on informed consent\radiation oncology. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 937-941.
7. United States Nuclear Regulatory Commission. § 35.75 release of individuals containing unsealed byproduct material or implants containing byproduct material 2007. Available at: http://www.nrc.gov/reading-rm/doc- collections/cfr/part035/part035-0075.html. Accessed March 18, 2009.
8. United States Nuclear Regulatory Commission. Regulatory guide 8.39, re¬lease of patients administered radioactive materials 1997. Available at: http://www.nucmed.com/nucmed/ref/8-39.pdf. Accessed March 18, 2009.
9. ACR practice guideline for the performance of thyroid scintigraphy and uptake measurements. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 845-849.
10. Nakada K, Ishibashi T, Takei T, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46:261-266. (Pubitemid 43073433)
11. Schraml FV, Parr LF, Ghurani S, et al. Autopsy of a cadaver containing strontium-89-chloride. J Nucl Med. 1997;38:380-382.
12. Williams G, Palmer MR, Parker JA, et al. Extravasation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case report. Cancer Biother Radiopharm. 2006;21:101-105. (Pubitemid 43830431)
13. ACR practice guideline for the performance of gastrointestinal scintigraphy. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 863-870.
14. ACR practice guideline for communication: radiation oncology. Practice Guidelines and Technical Standards. Reston, VA: American College of Radiology; 2008: 931-936.